摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(1-吡咯基)苯胺 | 52768-17-9

中文名称
4-(1-吡咯基)苯胺
中文别名
4-(1H-吡络)苯胺
英文名称
4-(1H-pyrrol-1-yl)aniline
英文别名
4-(1H-pyrrol-1-yl)benzenamine;4-(1H-pyrrole-1-yl) aniline;4-pyrrol-1-ylaniline
4-(1-吡咯基)苯胺化学式
CAS
52768-17-9
化学式
C10H10N2
mdl
MFCD01934575
分子量
158.203
InChiKey
NHLHWHRXMZZWGA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    81 °C
  • 沸点:
    307.8±25.0 °C(Predicted)
  • 密度:
    1.09±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    31
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi
  • 安全说明:
    S24/25
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2933990090
  • 危险性防范说明:
    P261,P280,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H332,H335
  • 储存条件:
    室温且干燥环境下使用。

SDS

SDS:e70b286af70c2b59a42421cec357413e
查看
Name: 4-(1h-pyrrol-1-yl)aniline 97% Material Safety Data Sheet
Synonym: 1-(4-Aminbophenyl)pyrrol
CAS: 52768-17-9
Section 1 - Chemical Product MSDS Name:4-(1h-pyrrol-1-yl)aniline 97% Material Safety Data Sheet
Synonym:1-(4-Aminbophenyl)pyrrol

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
52768-17-9 4-(1H-Pyrrol-1-yl)aniline 97% unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 52768-17-9: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 80.7 - 81.2 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H10N2
Molecular Weight: 158.2

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 52768-17-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-(1H-Pyrrol-1-yl)aniline - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 52768-17-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 52768-17-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 52768-17-9 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-(1-吡咯基)苯胺氢氧化钾sodium hydroxidepotassium carbonate 作用下, 以 二苯醚乙醇N,N-二甲基甲酰胺 为溶剂, 反应 8.17h, 生成
    参考文献:
    名称:
    Corelli; Massa; Stefancich, Farmaco, Edizione Scientifica, 1983, vol. 38, # 4, p. 219 - 231
    摘要:
    DOI:
  • 作为产物:
    描述:
    对氟硝基苯 在 hydrazine hydrate 、 palladium on activated charcoal 、 potassium carbonate 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 17.5h, 生成 4-(1-吡咯基)苯胺
    参考文献:
    名称:
    紫精衍生物电致变色材料及其制备方法
    摘要:
    本发明公开了紫精衍生物的电致变色材料及其制备方法;该制备方法以4,4'‑联吡啶为原料,与1‑氯‑2,4‑二硝基苯进行Menschutkin反应合成1,1'‑双(2,4‑二硝基)‑4,4'‑联吡啶盐;然后N‑杂环化合物与对氟硝基苯通过芳香族亲核胺化制备4‑硝基化合物,后将4‑硝基化合物还原为4‑氨基化合物;最后将上述二步反应的产物进行Zincke反应得到目标产物。本发明衍生物引入了吡咯基团和咔唑,改善了紫精化合物核心基团4,4'‑联吡啶上的缺电子状态,降低其电致变色电压;并可以得到双极性电致变色器件,实现更高的对比度,具有多种颜色变化,还可解决溶液型电致变色器件电解液泄漏的问题。
    公开号:
    CN110105336B
点击查看最新优质反应信息

文献信息

  • Alkylation of Amines with Alcohols and Amines by a Single Catalyst under Mild Conditions
    作者:Qingzhu Zou、Chao Wang、Jen Smith、Dong Xue、Jianliang Xiao
    DOI:10.1002/chem.201501109
    日期:2015.6.26
    An efficient catalytic system for the alkylation of amines with either alcohols or amines under mild conditions has been developed, using cyclometallated iridium complexes as catalysts. The method has broad substrate scope, allowing for the synthesis of a diverse range of secondary and tertiary amines with good to excellent yields. By controlling the ratio of substrates, both mono‐ and bis‐alkylated
    使用环金属化铱配合物作为催化剂,已经开发出一种在温和条件下将胺与醇或胺烷基化的有效催化体系。该方法具有广泛的底物范围,允许以良好或优异的产率合成多种范围的仲胺和叔胺。通过控制底物的比例,可以高选择性获得单烷基化胺和双烷基化胺。特别是,甲醇可用作烷基化试剂,选择性地提供N-甲基化产物。对于该反应观察到强溶剂作用。
  • Nickel-Catalyzed Monoarylation of Ammonia
    作者:Andrey Borzenko、Nicolas L. Rotta-Loria、Preston M. MacQueen、Christopher M. Lavoie、Robert McDonald、Mark Stradiotto
    DOI:10.1002/anie.201410875
    日期:2015.3.16
    diverse (hetero)aryl chloride, bromide, and tosylate electrophiles were employed in the Ni‐catalyzed monoarylation of ammonia, including chemoselective transformations. The employed JosiPhos/[Ni(cod)2] catalyst system enables the use of commercially available stock solutions of ammonia, or the use of ammonia gas in these reactions, thereby demonstrating the versatility and potential scalability of the reported
    结构多样的(杂)芳基氯,溴化物和甲苯磺酸盐亲电子体被用于Ni催化的氨单芳基化反应,包括化学选择性转化。所采用的JosiPhos / [Ni(cod)2 ]催化剂体系使得能够使用市售的氨气储备溶液,或在这些反应中使用氨气,从而证明了所报道方案的多功能性和潜在的可扩展性。原理验证实验证明,空气稳定的[(JosiPhos)NiCl 2 ]预催化剂可成功用于此类转化。
  • A P,N-Ligand for Palladium-Catalyzed Ammonia Arylation: Coupling of Deactivated Aryl Chlorides, Chemoselective Arylations, and Room Temperature Reactions
    作者:Rylan J. Lundgren、Brendan D. Peters、Pamela G. Alsabeh、Mark Stradiotto
    DOI:10.1002/anie.201000526
    日期:2010.6.1
    Amazing ammonia: A new air‐stable P,Nligand (Mor‐DalPhos) is reported that enables the palladium‐catalyzed cross‐coupling of ammonia to a variety of aryl chloride and aryl tosylate substrates with high chemoselectivity and, for the first time, at room temperature (see scheme; Ad=adamantyl, Ts=para‐toluenesulfonyl).
    惊人的氨气:据报道,一种新型的空气稳定的P,N-配体(Mor-DalPhos)使钯催化的氨气与多种具有高化学选择性的芳基氯和甲苯磺酸芳基酯的交叉偶联成为首次。 ,在室温下(参见方案; Ad =金刚烷基,Ts =对甲苯磺酰基)。
  • Fused heterocyclic compounds useful as kinase modulators
    申请人:Vaccaro Wayne
    公开号:US20070078136A1
    公开(公告)日:2007-04-05
    Compounds having the formula (1), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof, are usefuil as kinase modulators, including MK2 modulation, wherein one of E and F is a nitrogen atom and the other of E and F is a carbon atom, Z is N or CR 3 , and R 1 , R 2 , R 3 , X and Y are as defined herein.
    具有化学式(1)的化合物,以及其对映体、非对映体、药用可接受的盐,可用作激酶调节剂,包括MK2调节,其中E和F中的一个是氮原子,另一个是碳原子,Z是N或CR3,R1、R2、R3、X和Y如本文所定义。
  • [EN] NOVEL ULK1 INHIBITORS AND METHODS USING SAME<br/>[FR] NOUVEAUX INHIBITEURS D'ULK 1 ET LEURS MÉTHODES D'UTILISATION
    申请人:SALK INST FOR BIOLOGICAL STUDI
    公开号:WO2016033100A1
    公开(公告)日:2016-03-03
    In certain aspects, the invention provides a method for treating a disease or condition in a subject, the method comprising co-administering to a subject in need thereof a therapeutically effective amount of at least one ULK1-inhibiting pyrimidine, and a therapeutically effective amount of an mTOR inhibitor.
    在某些方面,该发明提供了一种治疗受试者疾病或病况的方法,该方法包括向需要的受试者联合给予至少一种ULK1抑制嘧啶的治疗有效量,以及mTOR抑制剂的治疗有效量。
查看更多